Receptor-mediated Endocytosis of Tissue-type Plasminogen Activator by Low Density Lipoprotein Receptor-related Protein on Human Hepatoma HepG2 Cells
Overview
Authors
Affiliations
Hepatic parenchymal cells play an essential role in the clearance of circulating tissue-type plasminogen activator (t-PA) in vivo as a major pathway in the regulation of plasma fibrinolytic activity. Previous studies have identified plasminogen activator inhibitor type 1 (PAI-1)-dependent t-PA-binding sites in the human hepatoma cell line HepG2. In this study, we demonstrate that receptor-mediated binding and endocytosis of the t-PA-PAI-1 complex are largely mediated by a recently identified low density lipoprotein receptor-related protein (LRP). A 39-kDa LRP receptor-associated protein that modulates ligand binding to LRP was found to bind specifically to HepG2 cells and to inhibit approximately 70-80% of specific 125I-t-PA.PAI-1 binding. This inhibition by the 39-kDa protein was not due to inhibition of complex formation between 125I-t-PA and PAI-1; instead, the 39-kDa protein inhibited 125I-t-PA.PAI-1 binding to LRP. Polyclonal anti-LRP antibody raised against purified human LRP also inhibited 70-80% of specific 125I-t-PA.PAI-1 binding. A similar extent of inhibition by the 39-kDa protein was also observed for 125I-t-PA.PAI-1 endocytosis and degradation. Chemical cross-linking experiments demonstrated the direct interaction between 125I-t-PA.PAI-1 and LRP on HepG2 cells as anti-LRP antibody, in addition to anti-t-PA and anti-PAI-1 antibodies, was able to immunoprecipitate the 125I-t-PA.PAI-1 complex following binding of 125I-t-PA.PAI-1 to HepG2 cells and cross-linking. This interaction of the t-PA.PAI-1 complex with LRP on HepG2 cells was also observed when the unlabeled t-PA.PAI-1 complex was cross-linked to [35S]methionine-labeled HepG2 cells. In addition, the direct binding of the 39-kDa protein to LRP on HepG2 cells was demonstrated by similar cross-linking experiments. Thus, these data clearly show that LRP is the major cell-surface receptor responsible for t-PA.PAI-1 complex binding and endocytosis on human hepatoma HepG2 cells and extend the multifunctional nature of LRP as an endocytosis receptor for several structurally and functionally distinct ligands.
Neuroserpin: structure, function, physiology and pathology.
DAcunto E, Fra A, Visentin C, Manno M, Ricagno S, Galliciotti G Cell Mol Life Sci. 2021; 78(19-20):6409-6430.
PMID: 34405255 PMC: 8558161. DOI: 10.1007/s00018-021-03907-6.
Das L, Azmoon P, Banki M, Mantuano E, Gonias S PLoS One. 2019; 14(11):e0224738.
PMID: 31697716 PMC: 6837328. DOI: 10.1371/journal.pone.0224738.
Auderset L, Landowski L, Foa L, Young K Stem Cells Int. 2016; 2016:2108495.
PMID: 26949399 PMC: 4754494. DOI: 10.1155/2016/2108495.
Gu R, Fu L, Jiang C, Xu Y, Wang X, Yu J PLoS One. 2015; 10(7):e0130440.
PMID: 26176694 PMC: 4503687. DOI: 10.1371/journal.pone.0130440.
LRP1 shedding in human brain: roles of ADAM10 and ADAM17.
Liu Q, Zhang J, Tran H, Verbeek M, Reiss K, Estus S Mol Neurodegener. 2009; 4:17.
PMID: 19371428 PMC: 2672942. DOI: 10.1186/1750-1326-4-17.